SEC Filing Summary: Bellevue Life Sciences Acquisition Corp. (BLAC)
Business Context and Reporting Period
This Form 8-K was filed on January 10, 2025, reporting events occurring on January 9, 2025. The registrant is Bellevue Life Sciences Acquisition Corp., a Special Purpose Acquisition Company (SPAC) incorporated in Delaware. The company is currently seeking an initial business combination and has not yet reported operating revenue.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, or margin data. The report focuses on debt obligations:
- Debt Instrument: Unsecured promissory notes issued to the company's sponsor, Bellevue Global Life Sciences Investors, LLC.
- Total Principal Amount: $1,690,000 (comprising notes of $1,200,000, $50,000, $140,000, and $300,000 issued between April and July 2024).
- Liquidity Impact: The filing details an extension of maturity dates rather than new liquidity inflows or outflows.
Material Changes
The primary material change is the amendment of existing promissory notes:
- Event: Extension of the maturity date for all outstanding promissory notes.
- New Maturity Date: The earlier of September 30, 2025, or the date the company consummates an initial business combination.
- Terms: No other terms of the promissory notes were amended.
Outlook, Risks, and Management Commentary
The filing indicates the company remains in the pre-business combination phase. The extension of the promissory notes suggests management is securing working capital runway to complete a merger by the new deadline. No specific guidance, risk factors, or unusual items were detailed in this specific report beyond the debt amendment.
Investor Verification Checklist
- Verify the total outstanding balance of the promissory notes ($1,690,000) and confirm no additional interest has accrued since the last filing.
- Confirm the company's current cash position to ensure it can meet operational expenses until the new maturity date of September 30, 2025.
- Review the full text of Exhibit 10.1 (Amendment to Promissory Notes) for any covenants or conditions not summarized in the 8-K.
- Monitor for updates on the status of the initial business combination, as the debt maturity is contingent upon this event.